As of Jan 13
| +0.80 / +2.01%|
The 17 analysts offering 12-month price forecasts for Imperva Inc have a median target of 45.00, with a high estimate of 55.00 and a low estimate of 30.00. The median estimate represents a +10.70% increase from the last price of 40.65.
The current consensus among 20 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.